Global biopharmaceutical company Takeda announced the launch of the enzyme replacement therapy for 'lysosomal storage disorders' (LSDs), in an attempt to expand its portfolio of rare disease therapies in India.
"Under 'lysosomal storage disorders', India has been recording prevalence of Hunter Syndrome, Gaucher Disease and Fabry Disease. To address these, Takeda brings to the market Idursulfase for Hunter Syndrome, Velaglucerase Alpha for Gaucher Disease and Agalsidase Alfa for Fabry Disease," the company said in a statement.
Niemann-Pick Disease
Niemann-Pick disease is a group of inherited metabolic disorders in which cholesterol and lipids accumulate in lysosomes, leading to organ damage.
Advertisement
‘Lysosomal storage disorders are inherited metabolic diseases that are characterized by an abnormal build-up of various toxic materials in the body's cells as a result of enzyme deficiencies.’
Tweet it Now
Fabry disease interferes with the body's ability to break down a specific fatty substance (globotriaosylceramide or Gb3). Over 8,000-10,000 people worldwide have been affected by the disease.
Hunter Syndrome is a serious genetic disorder that interferes with the body's ability to break down specific mucopolysaccharides, also known as glycosaminoglycans or GAGs. It primarily affects males.
Gaucher is a rare inherited metabolic condition that affects approximately one in 100,000 people. Patients with type-1 Gaucher disease may experience varying symptoms and degrees of disease severity, making it difficult to diagnose.
Source: IANS
Gaucher is a rare inherited metabolic condition that affects approximately one in 100,000 people. Patients with type-1 Gaucher disease may experience varying symptoms and degrees of disease severity, making it difficult to diagnose.
Source: IANS
Mucopolysaccharidosis
Mucopolysaccharidosis (MPS) are a group of inborn metabolic disorders due to the absence or malfunctioning of specific enzymes required to process molecules called glycosaminoglycans.
Advertisement
 Inborn Errors of MetabolismInborn errors of metabolism are genetic disorders that hamper the body's metabolism resulting in severe clinical manifestations. | Advertisement
|
Genetic Testing of Diseases
Genetic testing helps to confirm a genetic condition in an individual and involves q complex laboratory techniques
Advertisement
Recommended Reading
Latest Drug News
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial
Acne treatment with anti-hypertensive drug is a valuable alternative to antibiotics, say physicians.